Compare SoFi Technologies Inc (SOFI) vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SoFi Technologies Inc vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? SoFi Technologies Inc trades at $15.77 (market cap $20.23B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.35 (market cap $58.16B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 2.9× SoFi Technologies Inc's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays a 3.36% dividend while SoFi Technologies Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold SoFi Technologies Inc for 60 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 0 Days on average.
| SOFI | TAK | |
|---|---|---|
Market Cap | $20.23B | $58.16B |
Volume | 32,692,405 | 2,467,530 |
Sector | Financials | Health |
52-Week High | $32.21 | $19.05 |
52-Week Low | $15.15 | $13.23 |
Typical Hold Time | 60 Days | 0 Days |
Enterprise Value | $20.37B | $86.04B |
Dividend Yield | — | 3.36% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SOFI stock trades at $15.61, down 0.95% on the day, with a bearish technical signal and mixed sentiment. Revenue grew to $3.61B in 2025, with net income of $481.32M, but cash flow from operations remains negative. The company has beaten EPS estimates in recent quarters, with Q3 2026 results expected soon. Analyst consensus is a Buy with a $21.58 price target, though technical indicators suggest near-term pressure.
Outlook: SOFI offers growth potential with strong revenue expansion and a diversified fintech platform, but faces risks from negative operating cash flow, high valuation multiples, and sensitivity to interest rates. The stock's current discount to analyst targets may present opportunity, but investors should weigh execution risks and macroeconomic headwinds.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SoFi Technologies Inc
SoFi is a financial services company that was founded in 2011 and is currently based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020 the company also offers payment and account services for debit cards and digital banking.
Read more on SOFI →About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →
